Literature DB >> 29717063

Nuclear PTEN enhances the maturation of a microRNA regulon to limit MyD88-dependent susceptibility to sepsis.

Flavia Sisti1, Soujuan Wang1, Stephanie L Brandt1,2, Nicole Glosson-Byers1, Lindsey D Mayo3, Young Min Son1, Sarah Sturgeon2, Luciano Filgueiras1,4, Sonia Jancar4, Hector Wong5, Charles S Dela Cruz6, Nathaniel Andrews6, Jose Carlos Alves-Filho7, Fernando Q Cunha7, C Henrique Serezani8,2.   

Abstract

Sepsis-induced organ damage is caused by systemic inflammatory response syndrome (SIRS), which results in substantial comorbidities. Therefore, it is of medical importance to identify molecular brakes that can be exploited to dampen inflammation and prevent the development of SIRS. We investigated the role of phosphatase and tensin homolog (PTEN) in suppressing SIRS, increasing microbial clearance, and preventing lung damage. Septic patients and mice with sepsis exhibited increased PTEN expression in leukocytes. Myeloid-specific Pten deletion in an animal model of sepsis increased bacterial loads and cytokine production, which depended on enhanced myeloid differentiation primary response gene 88 (MyD88) abundance and resulted in mortality. PTEN-mediated induction of the microRNAs (miRNAs) miR125b and miR203b reduced the abundance of MyD88. Loss- and gain-of-function assays demonstrated that PTEN induced miRNA production by associating with and facilitating the nuclear localization of Drosha-Dgcr8, part of the miRNA-processing complex. Reconstitution of PTEN-deficient mouse embryonic fibroblasts with a mutant form of PTEN that does not localize to the nucleus resulted in retention of Drosha-Dgcr8 in the cytoplasm and impaired production of mature miRNAs. Thus, we identified a regulatory pathway involving nuclear PTEN-mediated miRNA generation that limits the production of MyD88 and thereby limits sepsis-associated mortality.
Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29717063      PMCID: PMC8147521          DOI: 10.1126/scisignal.aai9085

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  76 in total

1.  Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFkappaB activation without interfering with the IkappaB degradation pathway.

Authors:  D Koul; Y Yao; J L Abbruzzese; W K Yung; S A Reddy
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

Review 2.  Toll-like receptor signalling.

Authors:  Shizuo Akira; Kiyoshi Takeda
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  PTEN reduces cuff-induced neointima formation and proinflammatory cytokines.

Authors:  Shinichiro Koide; Masahiro Okazaki; Masahito Tamura; Kiyoshi Ozumi; Hiroyuki Takatsu; Fumihiko Kamezaki; Akihide Tanimoto; Hiromi Tasaki; Yasuyuki Sasaguri; Yasuhide Nakashima; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-02-02       Impact factor: 4.733

Review 4.  The history of Toll-like receptors - redefining innate immunity.

Authors:  Luke A J O'Neill; Douglas Golenbock; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2013-05-17       Impact factor: 53.106

5.  Inhibition of serum- and glucocorticoid-inducible kinase 1 enhances TLR-mediated inflammation and promotes endotoxin-driven organ failure.

Authors:  Huaxin Zhou; Shegan Gao; Xiaoxian Duan; Shuang Liang; David A Scott; Richard J Lamont; Huizhi Wang
Journal:  FASEB J       Date:  2015-05-20       Impact factor: 5.191

6.  Ubiquitination regulates PTEN nuclear import and tumor suppression.

Authors:  Lloyd C Trotman; Xinjiang Wang; Andrea Alimonti; Zhenbang Chen; Julie Teruya-Feldstein; Haijuan Yang; Nikola P Pavletich; Brett S Carver; Carlos Cordon-Cardo; Hediye Erdjument-Bromage; Paul Tempst; Sung-Gil Chi; Hyo-Jong Kim; Tom Misteli; Xuejun Jiang; Pier Paolo Pandolfi
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 7.  MicroRNA in TLR signaling and endotoxin tolerance.

Authors:  Md A Nahid; Minoru Satoh; Edward Kl Chan
Journal:  Cell Mol Immunol       Date:  2011-08-08       Impact factor: 11.530

Review 8.  MicroRNA-mediated control of macrophages and its implications for cancer.

Authors:  Mario Leonardo Squadrito; Martin Etzrodt; Michele De Palma; Mikael J Pittet
Journal:  Trends Immunol       Date:  2013-03-13       Impact factor: 16.687

9.  The inositol 3-phosphatase PTEN negatively regulates Fc gamma receptor signaling, but supports Toll-like receptor 4 signaling in murine peritoneal macrophages.

Authors:  Xianhua Cao; Guo Wei; Huiqing Fang; Jianping Guo; Michael Weinstein; Clay B Marsh; Michael C Ostrowski; Susheela Tridandapani
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

10.  Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells.

Authors:  Lian-Mei Zhong; Yi Zong; Lin Sun; Jia-Zhi Guo; Wei Zhang; Ying He; Rui Song; Wen-Min Wang; Chun-Jie Xiao; Di Lu
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

View more
  8 in total

1.  Myeloid cell-targeted miR-146a mimic inhibits NF-κB-driven inflammation and leukemia progression in vivo.

Authors:  Yu-Lin Su; Xiuli Wang; Mati Mann; Tomasz P Adamus; Dongfang Wang; Dayson F Moreira; Zhuoran Zhang; Ching Ouyang; Xin He; Bin Zhang; Piotr M Swiderski; Stephen J Forman; David Baltimore; Ling Li; Guido Marcucci; Mark P Boldin; Marcin Kortylewski
Journal:  Blood       Date:  2020-01-16       Impact factor: 22.113

Review 2.  PTEN: An Emerging Potential Target for Therapeutic Intervention in Respiratory Diseases.

Authors:  Bangrong Cai; Liu Yang; Young Do Jung; Ying Zhang; Xinguang Liu; Peng Zhao; Jiansheng Li
Journal:  Oxid Med Cell Longev       Date:  2022-06-30       Impact factor: 7.310

Review 3.  Metformin and Vascular Diseases: A Focused Review on Smooth Muscle Cell Function.

Authors:  Mingying Deng; Dan Su; Suowen Xu; Peter J Little; Xiaojun Feng; Liqin Tang; Aizong Shen
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

Review 4.  Non-Coding RNAs in Sepsis-Associated Acute Kidney Injury.

Authors:  Yanna Chen; Huan Jing; Simin Tang; Pei Liu; Ye Cheng; Youling Fan; Hongtao Chen; Jun Zhou
Journal:  Front Physiol       Date:  2022-04-08       Impact factor: 4.755

Review 5.  Expression of MicroRNAs in Sepsis-Related Organ Dysfunction: A Systematic Review.

Authors:  Aniello Maiese; Andrea Scatena; Andrea Costantino; Enrica Chiti; Carla Occhipinti; Raffaele La Russa; Marco Di Paolo; Emanuela Turillazzi; Paola Frati; Vittorio Fineschi
Journal:  Int J Mol Sci       Date:  2022-08-19       Impact factor: 6.208

6.  Macrophage-Derived MicroRNA-21 Drives Overwhelming Glycolytic and Inflammatory Response during Sepsis via Repression of the PGE2/IL-10 Axis.

Authors:  Paulo De Melo; Annie Rocio Pineros Alvarez; Xiang Ye; Amondrea Blackman; Jose Carlos Alves-Filho; Alexandra I Medeiros; Jeffrey Rathmell; Heather Pua; C Henrique Serezani
Journal:  J Immunol       Date:  2021-07-23       Impact factor: 5.426

Review 7.  Sepsis therapies: learning from 30 years of failure of translational research to propose new leads.

Authors:  Jean-Marc Cavaillon; Mervyn Singer; Tomasz Skirecki
Journal:  EMBO Mol Med       Date:  2020-03-16       Impact factor: 12.137

Review 8.  Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Normohammad Arefian
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.